Benzyl N-[2-phenyl-1-(phenylcarbamoyl)ethyl]carbamate

Catalog No. :
ACAFXZ894
CAS No. :
126787-17-5
Molecular Formula :
C23H22N2O3
Molecular Weight :
374.44

IUPAC Name:benzyl (1-oxo-3-phenyl-1-(phenylamino)propan-2-yl)carbamate

Benzyl N-[2-phenyl-1-(phenylcarbamoyl)ethyl]carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$137.00Login to see priceInquiryInquiry
5g97%$371.00Login to see priceInquiryInquiry
10g97%$645.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl N-[2-phenyl-1-(phenylcarbamoyl)ethyl]carbamate
IUPAC Namebenzyl (1-oxo-3-phenyl-1-(phenylamino)propan-2-yl)carbamate
MDL No.MFCD00731376
Molecular FormulaC23H22N2O3
Molecular Weight374.44
SMILESO=C(OCC1=CC=CC=C1)NC(C(NC2=CC=CC=C2)=O)CC3=CC=CC=C3
InChI KeyYWAZVNYQZYAOEY-UHFFFAOYSA-N
SynonymBenzyl N-[2-phenyl-1-(phenylcarbaMoyl)ethyl]carbaMate;N-benzyloxycarbonyl-DL-phenylalanine anilide;Carbamic acid, N-[2-oxo-2-(phenylamino)-1-(phenylmethyl)ethyl]-, phenylmethyl ester
CAS No.126787-17-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAFXZ894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWDCH259 route compound structure diagram
    ACWDCH2593588-57-6 In Stock
  4. Then
  5. ACAFXZ894 route product structure diagram
    ACAFXZ894126787-17-5
Inquiry

2. ACAFXZ894 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBRLA062 route compound structure diagram
    ACBRLA0621161-13-3 In Stock
  4. Then
  5. ACAFXZ894 route product structure diagram
    ACAFXZ894126787-17-5
Inquiry

Comments (0)